|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
SCIDIR_ocn861527705 |
003 |
OCoLC |
005 |
20231117044924.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
130919t20142014cauad ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d N$T
|d OPELS
|d CUI
|d OCLCQ
|d YDXCP
|d GGVRL
|d OCLCF
|d COO
|d VLB
|d OCLCQ
|d CASUM
|d MERER
|d OCLCQ
|d U3W
|d D6H
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 861477984
|a 875909563
|
020 |
|
|
|a 9780124115309
|q (electronic bk.)
|
020 |
|
|
|a 0124115306
|q (electronic bk.)
|
020 |
|
|
|z 9780124114647
|
020 |
|
|
|z 0124114644
|
035 |
|
|
|a (OCoLC)861527705
|z (OCoLC)861477984
|z (OCoLC)875909563
|
050 |
|
4 |
|a RC523
|b .G56 2014eb
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8310610724
|
245 |
0 |
0 |
|a Global clinical trials for Alzheimer's disease :
|b design, implementation, and standardization /
|c edited by Menghis Bairu, Michael Weiner.
|
264 |
|
1 |
|a San Diego, CA :
|b Academic Press,
|c [2014]
|
264 |
|
4 |
|c �2014
|
300 |
|
|
|a 1 online resource (xix, 407 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a I. Alzheimer's disease : the twenty-first century epidemic -- II. Global Alzheimer's disease : clinical trials -- III. Challenges and opportunities to conduct global Alzheimer's disease clinical trials -- IV. Global regulatory environment surrounding Alzheimer's disease trials -- V. Standardization of diagnostic and outcome measures in global Alzheimer's disease trials -- VI. Operationalization of global Alzheimer's disease trials -- VII. Enhancing low and middle income countries' capacity and capability to conduct Alzheimer's disease trials -- VIII. Pharmacogenetics and pharmacogenomics considerations -- IX. Human resources planning.
|
520 |
|
|
|a This book is a practical guide for researchers and physicians planning and conducting global clinical trials for Alzheimer's disease. It addresses important considerations that may arise during the successful design and execution of these trials, including site selection, local regulatory issues, pharmacogenomics, ethical matters and more.
|
650 |
|
0 |
|a Alzheimer's disease
|x Chemotherapy.
|
650 |
|
0 |
|a Drugs
|x Testing.
|
650 |
|
0 |
|a Clinical trials.
|
650 |
1 |
2 |
|a Alzheimer Disease
|x drug therapy
|0 (DNLM)D000544Q000188
|
650 |
1 |
2 |
|a Clinical Trials.
|
650 |
2 |
2 |
|a Internationality
|0 (DNLM)D038622
|
650 |
|
2 |
|a Clinical Trials as Topic
|0 (DNLM)D002986
|
650 |
|
6 |
|a Maladie d'Alzheimer
|x Chimioth�erapie.
|0 (CaQQLa)201-0330307
|
650 |
|
6 |
|a M�edicaments
|x Essais cliniques.
|0 (CaQQLa)201-0102966
|
650 |
|
6 |
|a �Etudes cliniques.
|0 (CaQQLa)201-0070699
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Alzheimer's disease
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00806536
|
650 |
|
7 |
|a Clinical trials
|2 fast
|0 (OCoLC)fst00864429
|
650 |
|
7 |
|a Drugs
|x Testing
|2 fast
|0 (OCoLC)fst00898940
|
650 |
|
7 |
|a Psychiatry.
|2 hilcc
|
650 |
|
7 |
|a Health & Biological Sciences.
|2 hilcc
|
650 |
|
7 |
|a Psychiatric Disorders, Individual.
|2 hilcc
|
700 |
1 |
|
|a Bairu, Menghis.
|
700 |
1 |
|
|a Weiner, Michael.
|
776 |
0 |
8 |
|i Print version:
|a Bairu, Menghis.
|t Global clinical trials for Alzheimer's disease.
|d San Diego, CA : Academic Press, �2014
|z 9780124114647
|w (OCoLC)863036333
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124114647
|z Texto completo
|